(Q34304706)

1 August 2017

1 reference

title

Clinical experience with endothelin receptor antagonists in chronic heart failure (English)

1 reference

1 August 2017

chronic heart failure

1 reference

Seed A

1

1 reference

1 August 2017

Love MP

series ordinal

2

1 reference

1 August 2017

McMurray JJ

series ordinal

3

1 reference

1 August 2017

language of work or name

1 reference

1 December 2001

1 reference

1 August 2017

Heart Failure Reviews

1 reference

1 August 2017

6

1 reference

1 August 2017

4

1 reference

1 August 2017

317-323

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1011408425878

1 August 2017

0 references

cites work

Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.

1 reference

12 December 2020

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.

1 reference

12 December 2020

Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure

1 reference

12 December 2020

Role of endothelin in the increased vascular tone of patients with essential hypertension

1 reference

12 December 2020

Acute hemodynamic and neurohumoral effects of selective ET(A) receptor blockade in patients with congestive heart failure. ET 003 Investigators

1 reference

12 December 2020

Regulation of aldosterone secretion in patients with chronic congestive heart failure by endothelins

1 reference

12 December 2020

Endothelin adrenocortical secretagogue effect is mediated by the B receptor in rats

1 reference

12 December 2020

Endothelin receptor antagonism in patients with chronic heart failure

1 reference

12 December 2020

Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans

1 reference

12 December 2020

Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure

1 reference

12 December 2020

Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure

1 reference

12 December 2020

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

1 reference

12 December 2020

Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.

1 reference

12 December 2020

Endothelin-1 potentiation of angiotensin II stimulation of aldosterone production

1 reference

12 December 2020

Vasodilator Effects of Endothelin-Converting Enzyme Inhibition and Endothelin ET A Receptor Blockade in Chronic Heart Failure Patients Treated With ACE Inhibitors

1 reference

12 December 2020

Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure

1 reference

12 December 2020

Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1011408425878

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference